Table 1B PRODH genetic variants, detected in our patient.

From: Hyperprolinemia type I caused by homozygous p.T466M mutation in PRODH

RefSNP ID

Nucleic acid

Amino acid

Location

Allele frequency in controls (%)

ClinVar

PolyPhen-2 (Score)

Human Splicing Finder

Ā rs2008720

c.56C>A

p.P19Q

Exon 2

83.68a,b, 29c

āˆ’

Benign

āˆ’

Ā rs4819756

c.553T>C

p.W185R

Exon 5

96.72a,b, 48c, 33.14d

āˆ’

Benign

āˆ’

Ā rs1808320

c.991T>C

p.L331=

Exon 9

83.74a,b

āˆ’

āˆ’

probably no impact on splicing

Ā rs1076466

c.1105–14C>T

āˆ’

Intron 10

80.89a,b, 39c

āˆ’

āˆ’

probably no impact on splicing

Ā rs2870984

c.1397C>T

p.T466M

Exon 12

2.36a,b, 1.40d

Conflicting interpretations of pathogenicity

Possibly damaging (0.943)

āˆ’

Ā rs2870983

c.1414G>A

p.A472T

Exon 12

3.96a,b, 5.31d, 10.29e, 7.02f

āˆ’

Benign

āˆ’

Ā rs455072

c.1515T>C

p.F505=

Exon 13

92.06a,b

āˆ’

āˆ’

probably no impact on splicing

Ā rs450046

c.1562G>A

p.R521Q

Exon 14

96.11a,b, 5.37d

āˆ’

Possibly damaging (0.507)

āˆ’

Ā rs372055

c.1741C>T

p.L581=

Exon 15

79.59a,b, 28.49d

Benign

āˆ’

probably no impact on splicing

  1. The variants which detected in our patient were all of homozygous. The c.1562 G > A (p.R521Q) was found in family members including the patient’s father, mother, brother, and sister as homozygous. They did not present with hyperprolinemia.
  2. aTadaka S, Saigusa D, Motoike IN, Inoue J, Aoki Y, Shirota M et al. jMorp: Japanese multi omics reference panel. Nucleic Acids Res 2018; 46: D551-D557.
  3. bTadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S et al. 3.5KJPNv2, An allele frequency panel of 3,552 Japanese Individuals including the X chromosome. Hum Genome Var. 2019; 6: 28.
  4. cWilliams HJ, Williams N, Spurlock G, Norton N, Zammit S, Kirov G et al. Detailed analysis of PRODH and PsPRODH reveals no association with schizophrenia. Am J Med Genet B 2003; 120: 42–46.
  5. dOta VK, Bellucco FT, Gadelha A, Santoro ML, Noto C, Christofolini DM et al. PRODH polymorphisms, cortical volumes and thickness in schizophrenia. PLoS ONE 2014; 9: e87686.
  6. eJacquet H, Raux G, Thibaut F, Hecketsweiler B, Houy E, Demilly C et al. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum Mol Genet 2002; 11: 2243–2249.
  7. fJacquet H, Demily C, Houy E, Hecketsweiler B, Raux G, Lerond J et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry 2005; 10: 479–485.